{"id":"1b15d2cb-c18f-5edf-a428-466ec3d08573","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-losing-the-shunt-enzyme","predicate":"causes","statement":"Of 95 patients in the database for whom age at diagnosis is recorded there are 40 individuals currently aged 18 years or older and only 3 patients were diagnosed after age 18 years, of 25 adults for whom data are available after age 18, 60% have a history of epilepsy with predominant seizure types being generalized tonic-clonic, absence and myoclonic, EEGs showed background slowing or generalized epileptiform discharges in two-thirds of adults, history of psychiatric symptoms was prominent with frequent anxiety, sleep disturbances and obsessive-compulsive disorder, and the illness had a progressive course with fatality at age 63 in the index case.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"75fe8c5d-1905-5c2c-be61-d8ac09e0ecbe","mechanism_event_label":"When the enzyme that disposes of GABA is missing, most affected adults have epilepsy and psychiatric illness, and the course gets worse.","subject":{"id":"364a6770-d592-5677-a61a-81e8ccf7b549","slug":"ssadh-deficiency","display_name":"Succinic semialdehyde dehydrogenase deficiency","entity_type_key":"cellular_process"},"object":{"id":"8367c617-f828-586c-b580-82f9e9746be6","slug":"epilepsy-in-ssadh","display_name":"Epilepsy in adults with succinic semialdehyde dehydrogenase deficiency","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"75fe8c5d-1905-5c2c-be61-d8ac09e0ecbe","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-losing-the-shunt-enzyme-event","event_type":"observed_intervention","label":"When the enzyme that disposes of GABA is missing, most affected adults have epilepsy and psychiatric illness, and the course gets worse.","description":"Of 95 patients in the database for whom age at diagnosis is recorded there are 40 individuals currently aged 18 years or older and only 3 patients were diagnosed after age 18 years, of 25 adults for whom data are available after age 18, 60% have a history of epilepsy with predominant seizure types being generalized tonic-clonic, absence and myoclonic, EEGs showed background slowing or generalized epileptiform discharges in two-thirds of adults, history of psychiatric symptoms was prominent with frequent anxiety, sleep disturbances and obsessive-compulsive disorder, and the illness had a progressive course with fatality at age 63 in the index case.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"2b49777d-ba80-59a7-a4f0-d19bb93c563f","slug":"aldh5a1","display_name":"Succinic semialdehyde dehydrogenase / ALDH5A1","entity_type_key":"protein"},"role":"missing_enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"462f63ce-a2c1-5312-9c14-70b8b12e1d6e","slug":"succinate","display_name":"Succinate","entity_type_key":"small_molecule"},"role":"downstream_product","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"364a6770-d592-5677-a61a-81e8ccf7b549","slug":"ssadh-deficiency","display_name":"Succinic semialdehyde dehydrogenase deficiency","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"8367c617-f828-586c-b580-82f9e9746be6","slug":"epilepsy-in-ssadh","display_name":"Epilepsy in adults with succinic semialdehyde dehydrogenase deficiency","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/gaba-research/26268900.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"23c46d68a8a23c3c561454ff56a07ff6ffa1311207b3fb462b079e21a7f6375c\", \"start_char\": 0, \"end_char\": 1604, \"text_sha256\": \"23c46d68a8a23c3c561454ff56a07ff6ffa1311207b3fb462b079e21a7f6375c\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Review of a clinical database cohort following identification of a patient diagnosed in the seventh decade","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Naturally occurring succinic semialdehyde dehydrogenase deficiency followed into adulthood","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A database review around an index case. The abstract reports the adult clinical picture; it does not report the accumulating metabolites, so nothing here rests on what backs up behind the missing enzyme.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.","comparator":null,"unit":null,"notes":"","entity":{"slug":"gaba","display_name":"Gamma-aminobutyric acid","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"When the enzyme that disposes of GABA is missing, most affected adults have epilepsy and psychiatric illness, and the course gets worse.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[gb-p26268900] Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood. (2015). https://pubmed.ncbi.nlm.nih.gov/26268900/ DOI: 10.1212/wnl.0000000000001906","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Whole body","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"507f2a07-0109-54d2-8b88-1cdb2e38da34","evidence_kind":"source_excerpt","locator":"Lines 157-168","start_line":157,"end_line":168,"excerpt":"### gb-losing-the-shunt-enzyme\nOf 95 patients in the database for whom age at diagnosis is recorded there are 40 individuals currently aged 18 years or older and only 3 patients were diagnosed after age 18 years, of 25 adults for whom data are available after age 18, 60% have a history of epilepsy with predominant seizure types being generalized tonic-clonic, absence and myoclonic, EEGs showed background slowing or generalized epileptiform discharges in two-thirds of adults, history of psychiatric symptoms was prominent with frequent anxiety, sleep disturbances and obsessive-compulsive disorder, and the illness had a progressive course with fatality at age 63 in the index case.\nCondition category: normal\nnutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.\nplain_language: When the enzyme that disposes of GABA is missing, most affected adults have epilepsy and psychiatric illness, and the course gets worse.\norganism: Human\ntissue_or_cell_type: Whole body\nexperimental_model: Review of a clinical database cohort following identification of a patient diagnosed in the seventh decade\nlimitations: A database review around an index case. The abstract reports the adult clinical picture; it does not report the accumulating metabolites, so nothing here rests on what backs up behind the missing enzyme.\nexposure: Naturally occurring succinic semialdehyde dehydrogenase deficiency followed into adulthood\nevidence_span: {\"source_cache\": \"artifacts/gaba-research/26268900.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"23c46d68a8a23c3c561454ff56a07ff6ffa1311207b3fb462b079e21a7f6375c\", \"start_char\": 0, \"end_char\": 1604, \"text_sha256\": \"23c46d68a8a23c3c561454ff56a07ff6ffa1311207b3fb462b079e21a7f6375c\"}\n[gb-p26268900] Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood. (2015). https://pubmed.ncbi.nlm.nih.gov/26268900/ DOI: 10.1212/wnl.0000000000001906","model_system":"Review of a clinical database cohort following identification of a patient diagnosed in the seventh decade","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [gb-p26268900] Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood. (2015). https://pubmed.ncbi.nlm.nih.gov/26268900/ DOI: 10.1212/wnl.0000000000001906","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"197c25bb-45fa-5e97-b3ab-2d2eff4e0d0a","stable_key":"import-1b599eb7-b22a-5fda-bcf0-9d92b5ae1311","title":"GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"07e36027ff70dbbe5563cddfa4758fd9b9b6eec148faecccafd476900b770456","revision_id":"a12d61de-f189-5bda-af3d-f31a1e61bccf","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}